Precision Medicine Institute, UPMC get $2.8M grant

The Pitt Institute for Precision Medicine and UPMC received a three-year $2.8 million grant from the Richard King Mellon Foundation for implementation of precision medicine initiatives, including whole genome sequencing of critically ill infants, genomics education and translational research pilot projects intended for commercialization.

The IPM, a joint effort of Pitt and UPMC, was created in 2013 to help researchers and clinicians discover features about an individual’s risk of disease, select best treatments and predict treatment response, and move these insights into clinical practice.  

“UPMC and Pitt are regional and national leaders in developing and implementing precision medicine efforts in the clinic,” said Adrian Lee (pictured), director of the IPM and professor of pharmacology and chemical biology at Pitt. “This grant will advance research and clinical care, and also help drive the field forward by commercializing technologies that have the potential to impact people at scale.”